Chinese herbal medicines group puts down US roots through acquisition
This article was originally published in Scrip
Executive Summary
Multinational pharma companies usually buy Chinese firms for quick access to the Chinese market, but now one traditional Chinese medicine (TCM) company is using the same tactic to expand in the West. China Health Resource (CHRI), based in Suining, Sichuang province, has filed a letter of intent to acquire up to 100% of Herborium Group, a US operation specialising in botanical products.